Answers are grounded in this paper and cite their sources.
This research shows reverse proteolysis connects cysteine cathepsins to autoimmunity, suggesting new avenues for understanding diseases.
Proteases are classically viewed as degradative enzymes, yet they can also catalyze reverse proteolysis, a reaction known for decades but rarely examined in disease contexts. Here, we show that cysteine cathepsins efficiently form multi-generational fusion peptides, including chimeras between viral/bacterial and human proteins, revealing a hidden layer of peptidome complexity with direct relevance to autoimmunity. Importantly, we demonstrated that this activity is pH dependent, favored by citrullination, and may represent up to 4.5% of the protease activity. Moreover, we identified cathepsin S-generated type 1 diabetes superagonists, directly linking reverse proteolysis to a clinically established autoantigen. To capture these rare products in a cellular environment, we developed a click chemistry-based technology. These findings expand the protease functional paradigm and uncover a hidden source of disease-relevant antigens.
No takes yet. Share an insight, caveat, or question.
Dakhili et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: